Format

Send to

Choose Destination
J Am Acad Dermatol. 2014 Feb;70(2):338-51. doi: 10.1016/j.jaad.2013.10.010. Epub 2013 Nov 27.

Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis.

Author information

1
Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital San Diego, San Diego, California.
2
Department of Dermatology, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.
3
Department of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina.
4
Department of Dermatology, Oregon Health and Science University, Portland, Oregon.
5
Department of Dermatology, University of California San Francisco, San Francisco, California.
6
Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada.
7
Ronald O. Perelman Department of Dermatology, New York University School of Medicine, New York, New York.
8
Department of Dermatology, Case Western University, Cleveland, Ohio.
9
Department of Dermatology, Mayo Clinic, Rochester, Minnesota.
10
Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.
11
Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
12
Division of Dermatology, Fletcher Allen Health Care, Burlington, Vermont.
13
Private practice, Fairfax, Virginia.
14
Centre of Evidence-Based Dermatology, Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.
15
Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama.
16
National Eczema Association, San Rafael, California.
17
American Academy of Dermatology, Schaumburg, Illinois.
18
American Academy of Dermatology, Schaumburg, Illinois. Electronic address: wsmithbegolka@aad.org.
19
Department of Dermatology, Seattle Children's Hospital, Seattle, Washington.

Abstract

Atopic dermatitis (AD) is a chronic, pruritic, inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in the management and care of AD, providing updated and expanded recommendations based on the available evidence. In this first of 4 sections, methods for the diagnosis and monitoring of disease, outcomes measures for assessment, and common clinical associations that affect patients with AD are discussed. Known risk factors for the development of disease are also reviewed.

KEYWORDS:

AAD; AD; ADHD; American Academy of Dermatology; CDLQI; Children's Dermatology Life Quality Index; DFI; DLQI; Dermatitis Family Impact; Dermatology Life Quality Index; EASI; Eczema Area and Severity Index; FLG; GREAT; Global Resource for Eczema Trials; IGA; IL; ISAAC; IgE; International Study of Asthma and Allergies in Childhood; Investigator's Global Assessment; MDC; POEM; Patient-Oriented Eczema Measure; SASSAD; SCORAD; SCORing Atopic Dermatitis; SORT; Six Area, Six Sign Atopic Dermatitis; TARC; TISS; Three-Item Severity Scale; UK; United Kingdom; assessment scales; atopic dermatitis; attention deficit hyperactivity disorder; biomarkers; clinical associations; criteria; diagnosis; filaggrin; immunoglobulin E; interleukin; macrophage-derived chemoattractant; risk factors; strength of recommendation taxonomy; thymus and activation-regulated chemokine

PMID:
24290431
PMCID:
PMC4410183
DOI:
10.1016/j.jaad.2013.10.010
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Elsevier Science Icon for PubMed Central
Loading ...
Support Center